Literature DB >> 2495830

Cooperative effects of gamma-interferon and 1 alpha, 25-dihydroxyvitamin D3 on in vitro differentiation of the blast cells of RAEB and RAEB-T.

K Tohyama1, S Ohmori, T Ueda, Y Ueda, H Sakoda, Y Yoshida, H Uchino.   

Abstract

We added recombinant human gamma-interferon (gamma-IFN) and 1 alpha, 25-dihydroxyvitamin D3 (1 alpha, 25 (OH)2D3) to the bone marrow cells from six patients with RAEB or RAEB-T in liquid suspension cultures. After cultivation for 7 to 9 days, numerical, morphological and functional changes of the cells were assessed. gamma-IFN and 1 alpha, 25 (OH)2D3 additively suppressed cell growth, especially the number of blast cells decreased. The expression of alpha-naphthylbutyrate esterase (NBE) activity appeared to be promoted but that of naphthol AS-D chloroacetate esterase (NAE) activity was apparently suppressed by the addition of gamma-IFN and/or 1 alpha, 25 (OH)2D3. The percentage of NBT reduction-positive cells and latex-phagocytizing cells was only slightly increased by both agents. These results indicate that gamma-IFN and 1 alpha, 25 (OH)2D3 cooperate to induce monocytoid differentiation of the patients' blast cells. Combination therapy with both agents merits further study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495830     DOI: 10.1007/bf00320770

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line.

Authors:  E D Ball; A L Howell; L Shen
Journal:  Exp Hematol       Date:  1986-12       Impact factor: 3.084

2.  Effects of recombinant G-CSF and GM-CSF on in vitro differentiation of the blast cells of RAEB and RAEB-T.

Authors:  K Tohyama; S Ohmori; M Michishita; T Ueda; Y Ueda; H Sakoda; Y Yoshida; H Uchino
Journal:  Eur J Haematol       Date:  1989-04       Impact factor: 2.997

3.  Cooperative effects of gamma interferon and 1-alpha,25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells.

Authors:  J B Weinberg; M A Misukonis; M M Hobbs; M J Borowitz
Journal:  Exp Hematol       Date:  1986-02       Impact factor: 3.084

4.  Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

Authors:  S W Mamus; S Beck-Schroeder; E D Zanjani
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

5.  Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.

Authors:  H E Broxmeyer; L Lu; E Platzer; C Feit; L Juliano; B Y Rubin
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

6.  Variable differentiation patterns of acute myelogenous leukaemia blasts in liquid suspension cultures.

Authors:  M R Baer; E N Dessypris; R S Stein; J B Cousar; S B Krantz
Journal:  Br J Haematol       Date:  1987-06       Impact factor: 6.998

7.  Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.

Authors:  A Nagler; I Riklis; Y Kletter; I Tatarsky; I Fabian
Journal:  Exp Hematol       Date:  1986-01       Impact factor: 3.084

8.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.

Authors:  H P Koeffler; T Amatruda; N Ikekawa; Y Kobayashi; H F DeLuca
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.

Authors:  H P Koeffler; K Hirji; L Itri
Journal:  Cancer Treat Rep       Date:  1985-12

10.  In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives.

Authors:  I Fabian; I Riklis; I Tatarsky; A Nagler
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  1 in total

1.  Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes.

Authors:  G De Sanctis; V Bottari; A Frezzolini; M Ficcardi; G De Rossi; M C Petti; F Mandelli; L Fontana
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.